The Pulse Healthcare Innovation Breakfast Series

Brad Hirsch

Health Wildcatters’ next speaker at The Pulse Healthcare Innovation Breakfast Series will explore how to bring clinical research into the 21st century.

The Oct. 5 event will feature Dr. Brad Hirsch, CEO of SignalPath, a clinical research company that leverages technology to make clinical trials more efficient and effective. In addition to leading SignalPath, Hirsch is  a practicing medical oncologist at Texas Oncology and serves as a special advisor to Highlander Partners, a Dallas-based private equity fund. He previously was the senior medical director for Flatiron Health, a data and analytics company in oncology valued at over $1 billion, and a faculty member at Duke University.

Networking for the Oct. 5 program will begin at 7:30 a.m., with Hirsch taking the stage at 8 a.m., at Health Wildcatters’ office, located on the 20th floor of 1910 Pacific Ave. in downtown Dallas. Coffee and a continental breakfast will be provided.

The Pulse Healthcare Innovation Breakfast Series aims to connect entrepreneurs, medical professionals, and innovators in the healthcare and business communities of Dallas-Fort Worth.

For more information and for tickets, click here.